You are here

  • Home
  • Online First
  • Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with Medicare

Article info

Article menu
Download PDFPDF
Original research
Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with Medicare

Authors

  1. Correspondence to Dr Roni Nitecki Wilke, Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; rnitecki{at}mdanderson.org
View Full Text

Citation

Knisely A, Wu C, Kanbergs A, et al
Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with Medicare
International Journal of Gynecologic Cancer Published Online First: 30 July 2024. doi: 10.1136/ijgc-2024-005599

Publication history

  • Received April 8, 2024
  • Accepted June 18, 2024
  • First published July 30, 2024.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.